Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098851 · ClinicalTrials.gov registry record
Oxygen Saturation Monitoring During Surgery
A clinical trial of Sleep Apnea, Obstructive, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT01098851 is a study of Sleep Apnea, Obstructive that has completed, run by Medtronic - MITG. The registered enrollment target is 21 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01098851, a study of Sleep Apnea, Obstructive, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with Obstructive Sleep Apnea (OSA) have cyclical patterns of lower blood oxygen during sleep because of repeated episodes of upper airway obstruction that cause their breathing to stop. When these patients have surgery, anesthetic drugs may worsen these patterns of lower blood oxygen. This study monitors ten patients at high risk for OSA and ten patients at low risk for OSA during surgery. Patterns of lower oxygen saturations should arise in the high risk group but not the low risk group.
Conditions Studied
Study Locations (1)
Colorado
- Avista Adventist Hospital - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098851
The ClinicalTrials.gov registry entry for NCT01098851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 0 interventions.
NCT01098851 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01098851 about?
NCT01098851 is a clinical study titled "Oxygen Saturation Monitoring During Surgery". Patients with Obstructive Sleep Apnea (OSA) have cyclical patterns of lower blood oxygen during sleep because of repeated episodes of upper airway obstruction that cause their breathing to stop. When these patients have surgery, anesthetic drugs may worsen these patterns of lower blood oxygen. This ...
What is the current status of trial NCT01098851?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2009-07. Estimated completion is 2009-11.
What conditions does trial NCT01098851 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
Who is sponsoring clinical trial NCT01098851?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01098851 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
-
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RECRUITING · Phase 3
-
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.